Aesthetic company Sinclair has announced that one million syringes of Ellansé were sold last year, achieving a landmark milestone.
Ellansé launched in 2009 and has earned its place as a trusted product in the aesthetics industry. The dual action collagen stimulating dermal filler works deep under the skin to treat causes of facial ageing. By using the body’s natural response to encapsulate microspheres in the gel, it stimulates the production of connective tissue (collagen).
“We are delighted to announce that one million syringes of Ellansé have been sold”, says Dawn Thomson, Ellansé brand manager. “This accomplishment highlights our commitment to providing best in class training and is a testament to Ellanse’s enviable results and safety record. We extend our heartfelt thanks to our dedicated team, partners, key opinion leaders, and healthcare professionals who contributed to this incredible success.”
